Related Experiment Video

Updated: Mar 5, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

31.0K

Updates on hepatitis C virus therapy in the direct-acting antiviral era

Ramakrishna Behara1, Nancy Reau

  • 1Section of Hepatology, Rush University Medical Center, Chicago, Illinois, USA.

Current Opinion in Gastroenterology
|March 29, 2017
PubMed

Insights

Direct-acting antivirals (DAAs) offer improved treatment for Hepatitis C virus (HCV) infection, with better efficacy and fewer side effects than older therapies. New agents show promise for challenging patient groups.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge, leading to severe complications like cirrhosis and liver cancer.
  • Chronic HCV infection historically required interferon-based treatments with significant side effects.

Purpose of the Study:

  • To review current Hepatitis C virus (HCV) therapies.
  • To provide an overview of emerging direct-acting antiviral (DAA) agents.
  • To inform practitioners about new therapeutic options for HCV.

Main Methods:

  • Literature review of clinical studies and therapeutic guidelines.
  • Analysis of efficacy and safety data for direct-acting antivirals (DAAs).
  • Synthesis of information on novel agents for difficult-to-treat HCV populations.

Main Results:

  • Direct-acting antivirals (DAAs) have revolutionized HCV treatment, achieving high cure rates with improved tolerability.
  • Significant advancements in eradicating the virus have been observed with DAAs.
  • Emerging therapies demonstrate success in patient populations previously considered difficult to manage.

Conclusions:

  • DAAs represent a major breakthrough in managing Hepatitis C virus (HCV) infection.
  • Ongoing research is yielding new agents for diverse patient groups.
  • Practitioners can anticipate expanded therapeutic options for HCV treatment.
Abstract

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.1K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
346
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
692
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K